| RPHM Market Cap History Table | ||||||||||||||||||||||||||||||||
Below is a table of the RPHM market cap history going back to 4/9/2021:
Also see: RPHM Shares Outstanding History and RPHM YTD Return |
RPHM Market Cap History — Reneo Pharmaceuticals Capitalization Over Time
As of 8/8/2024 Reneo Pharmaceuticals has a market cap of 45.13 million. Investors often follow the RPHM market cap history to compare the size of the company over time.
This page shows RPHM market capitalization trends over time, with 15 market cap datapoints presented, dating back to 4/9/2021.
| RPHM Market Cap History Chart | |||||||||||||||||||||||||||||||||
RPHM Historical Market Cap: -45.25% CAGR 
Mouse over chart for data details
| |||||||||||||||||||||||||||||||||
| RPHM Stock Price Chart |
| About OnKure Therapeutics Inc |
| Reneo Pharmaceuticals is a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare genetic mitochondrial diseases, which are often associated with the inability of mitochondria to produce adenosine triphosphate. Co.'s primary product candidate, REN001, is a potent and selective agonist of the peroxisome proliferator-activated receptor delta. Co. is developing REN001 in rare genetic diseases that typically present with myopathy and have high unmet medical needs, including primary mitochondrial myopathies and long-chain fatty acid oxidation disorders. We show 15 historical shares outstanding datapoints in our RPHM shares outstanding history coverage, used to compute RPHM market cap on those dates. Understanding the changing numbers of shares outstanding, the changing share price, and the resulting changing RPHM market cap history over the course of time is important for investors interested in comparing RPHM's market cap history versus its peers. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies, and then calculating their respective market caps. Comparing the share price of RPHM versus a peer is one thing; comparing RPHM market cap versus a peer is a completely different story. Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares), the market cap for a company like RPHM can fluctuate over the course of history. With this page we aim to empower investors researching RPHM by allowing them to research the RPHM market cap history. |
| RPHM Current Stock Quote |
Quotes delayed 20 minutes  Free RPHM Email Alerts:
Get Dividend Alerts 
Get SEC Filing Alerts
|
| Video: The Importance of Market Cap | |
|
Video: The Importance of Market Cap
| RPHM Share Performance |
| Market Cap Peers |
| Reneo Pharmaceuticals (RPHM) is categorized under the Healthcare sector; to help you further research historical market cap numbers, below are some other companies in the same sector:
RPID Market Cap History RPRX Market Cap History RSLS Market Cap History RTIX Market Cap History RTRX Market Cap History RTTR Market Cap History RUBY Market Cap History RVMD Market Cap History RVNC Market Cap History RVPH Market Cap History More Healthcare companies » |
RPHM Market Cap History | www.MarketCapHistory.com | Copyright © 2017 - 2026, All Rights Reserved
Nothing in MarketCapHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners.
None of the information contained herein constitutes a recommendation that any particular security, portfolio,
transaction, or investment strategy is suitable for any specific person. All viewers agree that under no
circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held
liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you
agree to the following Full Disclaimer & Terms of Use and
Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at
least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
